Intellia Therapeutics
NTLA
#6021
Rank
S$0.95 B
Marketcap
$9.21
Share price
-5.62%
Change (1 day)
-72.63%
Change (1 year)

Earnings for Intellia Therapeutics (NTLA)

Earnings in 2024 (TTM): -S$0.7 Billion

According to Intellia Therapeutics's latest financial reports the company's current earnings are S$57.87 Million. a decrease over its 2023 earnings that were of -S$0.65 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Intellia Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 -S$0.7 Billion7.86%
2023 -S$0.65 Billion1.48%
2022 -S$0.64 Billion77.01%
2021 -S$0.36 Billion99.58%
2020 -S$0.18 Billion34.86%
2019 -S$0.14 Billion16.63%
2018 -S$0.12 Billion26.35%
2017 -S$90.34 Million113.51%
2016 -S$42.31 Million135.92%
2015 -S$17.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.2 Billion-72.47%๐Ÿ‡บ๐Ÿ‡ธ USA